Neuropeptides in the sympathetic system: Presence, plasticity, modulation, and implications

Annals of Neurology

Volumn 36, Issue 1, 1994, Pages 6-13

  Benarroch, Eduardo E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CALCITONIN GENE RELATED PEPTIDE; ENKEPHALIN; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR; NORADRENALIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

AGING; DIABETES MELLITUS; DYSAUTONOMIA; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; REVIEW; SYMPATHECTOMY; SYMPATHETIC GANGLION;

AGING; ANIMAL; AUTONOMIC NERVOUS SYSTEM DISEASES; CATS; DIABETIC NEUROPATHIES; GANGLIA, SYMPATHETIC; HUMAN; HYPOTHALAMUS; MEDULLA OBLONGATA; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEUROPEPTIDE Y; NEUROPEPTIDES; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 0028284297     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410360105     Document Type: Article

References (78)

1. Chemical codingof neurons and plurichemical transmission
2. The chemical neuroanatomy of sympathetic ganglia
3. Structural and chemical organization of the autonomic nervous system with speical reference to non‐adrenergic, non‐cholinergic transmission
4. Characteristics of function‐specific pathways in the sympathetic nervous system
5. Neurotransmitter plasticity in sympathetic neurons
6. Neuropeptide Y–related peptides and their receptors—are the receptors potential therapeutic drug targets?
7. Peripheral sympathetic neural activity in conscious humans
8. Sympathoexcitatory neurons of the rostroventrolateral medulla and the origin of the sympathetic vasomotor tone
9. Neurochemical organization of the hypothalamic projection to the spinal cord in the rat
10. CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transeuronal cell body lebeling with pseudorbaies virus
11. Tachykinins in autonomic control systems. The company they keep
12. Neuropeptide regulation of autonomic outflow at the sympathetic preganglionic neuron. Anatomical and neuro‐chemical specificity
13. Pilomotor and secretomotor neurons distinguished by size and neuropeptide content in superior cervical ganglia of mice
14. Peripheral autonomic nervous system
15. Brain Structural and functional aspects of acetylcholine peptide coexistence in the autonomic nervous system
16. Neuropeptides in the human superior cervical ganglion
17. Localization of neuropeptide Y in human sympathetic ganglia: correlation with met‐enkephalin, tyrosine hydroxylase and acetylcholinesterase
18. Dynorphin‐containing pilomotor neurons in the superior cervical ganglion of guinea pigs
19. , vasodilator and pilomotor patways in sympathetic ganglia of guinea‐pigs
20. Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene‐related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries
21. Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function
22. Peptides and vasomotor mechanisms
23. Peptidergic innervation of the cerebral circulation. Role in subarachnoid hemorrhage in man
24. Comparison of the inhibitory roles of neuropeptide Y and galanin on cardiac vagal action in the dog
25. Coexistence of calcitonin gene‐related peptide and vasoactive intestinal peptide in cholinergic sympathetic innervation of rat sweat glands
26. CRF‐like immunoreactivity selectivity labels preganglionic sudomotor neurons in cat
27. Somatostatinlike immunoreactivity in human sympathetic ganglia
28. Phenotypic plasticity in adult sympathetic neurons: changes in neuropeptide expression in organ culture
29. Neuropeptide Y mRNA regulation in rat sympathetic ganglia: effect of reserpine
30. Regulation of substance P expression in sympathetic neurons
31. Effects of antibodies against acetylcholinesterase on the expression of peptides and catecholamine synthesizing enzymes in the rat adrenal gland
32. On the fate of sympathetic and sensory neurons projecting into a neuroma of the superficial peroneal nerve in the cat
33. Increase in SP‐like immunoreactivity in nerve fibres of rabbit iris and ciliary body one to four months following sympathetic denervation
34. The effect of sympathectomy on calcitonin gene‐related peptide levels in the rat trigeminovascular system
35. Guanethidine sympathectomy of mature rats leads to increases in calcitonin gene‐related peptide and vasoactive intestinal polypeptide‐containing nerves
36. Guanethidine sympathectomy increases substance P concentration in the superior sympathetic ganglion of adult rats
37. Appearance of the noradrenergic markers tyrosine hydroxylase and neuropeptide Y in cholinergic nerves of the iris following sympathectomy
38. Persistence of intrinsic neurones and possible phenotypic changes after extrinsic denervation of human respiratory tract by heart‐lung transplantation
39. Changes in expression of autonomic nerves in aging and disease
40. Immunohistochemical characterization of NPY and substance P containing nerve terminals in aged and diabetic human sympathetic ganglia
41. Evidence forthe coexistence of acetylcholine and enkephalin in the sympathetic preganglionic neurons of rats
42. Localization of [met5]‐ and [leu5]‐enkephalin‐like immunoreactivity in nerve terminals in human paravertebral sympathetic ganglia
43. Substance P‐immunoreactive peripheral branches of sensory neurons innervate guinea pig sympathetic neurons
44. Calcitionic gene‐related peptide containing sympathetic preganglionic and sensory neurons projecting to the superior cervical ganglion of the rat
45. Cholinergic sympathetic neurons
46. Receptor binding sites for cholecystokinin, galanin, somatostatin, substance P and vasoactive intestinal polypeptide in sympathetic ganglia
47. Enkephalinergic modulation of non‐cholinergic transmission in mammalian prevertebral ganglia
48. Dynamics of neurotensin stores in the stellate ganglion of the cat
49. Substance P and noncholinergic excitatory synaptic transmission in guinea‐pig sympathetic ganglia
50. Depolarization and muscarinic excitation induced in a sympathetic ganglion by vasoactive intestinal polypeptide
51. The electrophysiological effects of vasoactive intestinal polypeptide in the guinea‐pig inferior meseteric ganglion
52. Regulation of the concentration of adenosine 3′,5′‐cyclic monophosphate and the activity of tyrosine hydroxylase in the rat superior cervical ganglion by three neuropeptides of the secretin family
53. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues
54. Frequency‐and reserpine‐dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen
55. Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide
56. Mechanism of presynaptic inhibition by neuropeptide Y at sympathetic nerve terminals
57. Characterization, and DNA sequence of a human cDNA encoding neuropeptide tyrosine
58. Cloned human neuropeptide Y receptor couples to two different second messenger systems
59. Expression of the human neuropeptide tyrosine Y1 receptor
60. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man
61. Neuropeptide Y–like immunoreactivity of plasma during hypoglycaemia in man
62. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure
63. Baroreflex modulation of sympathetic activity and sympathetic neurotransmitters in humans
64. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans
65. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man
66. Clinical autonomic neuropharmacology
67. Marked depletion of dorsal spinal cord substance P and calcitonin gene‐related peptide with intact skin flare responses in multiple system atrophy
68. Autonomic ganglia in multiple system atrophy and pure autonomic failure
69. Plasma neuropeptide Y (NPY) and galanin before and during exercise in type 1 diabetic patients with autonomic dysfunction
70. Increased density of perivascular nerves to the major cerebral vessels of the spontaneously hypertensive rat: differential changes in noradrenaline and neuropeptide Y during development
71. Circadian regulation of the biosynthesis of cardiac met‐enkephalin and precursors in normotensive and spontaneously hypertensive rats
72. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects
73. Increased plasma levels of neuropeptide Y‐like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man
74. Normalization of blood pressure and plasma concentrations of beta‐endorphin and leucine‐enkephalin in patients with primary hypertension after treatment with clonidine
75. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma
76. Measurement of carecholamines, met‐enkephalin, somatostatin and substance P‐like immunoreactivities in 12 human pheochromocytomas
77. Changes in the levels of neuropeptide Y‐LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm
78. Increased neuropeptide Y concentrations in cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage